Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Ophthalmology

  Free Subscription


Articles published in J Ocul Pharmacol Ther

Retrieve available abstracts of 67 articles:
HTML format



Single Articles


    November 2021
  1. CHALIMESWAMY A, Thanuja MY, Ranganath SH, Pandya K, et al
    Oxidative Stress Induces a Breakdown of the Cytoskeleton and Tight Junctions of the Corneal Endothelial Cells.
    J Ocul Pharmacol Ther. 2021 Nov 23. doi: 10.1089/jop.2021.0037.
    PubMed     Abstract available


  2. LANDOWSKI M, Bowes Rickman C
    Targeting Lipid Metabolism for the Treatment of Age-Related Macular Degeneration: Insights from Preclinical Mouse Models.
    J Ocul Pharmacol Ther. 2021 Nov 17. doi: 10.1089/jop.2021.0067.
    PubMed     Abstract available


    October 2021
  3. CHEN L, Qu L, Gui Q, Wang S, et al
    Effects of Anti-Vascular Endothelial Growth Factor Drugs Before and After Pars Plana Vitrectomy in Patients with Polypoidal Choroidal Vasculopathy and Vitreous Hemorrhage.
    J Ocul Pharmacol Ther. 2021 Oct 22. doi: 10.1089/jop.2021.0039.
    PubMed     Abstract available


  4. SHELLEY H, Annaji M, Smith FT, Babu RJ, et al
    Difluprednate-Hydroxypropyl-beta-Cyclodextrin-Based Ophthalmic Solution for Improved Delivery in a Porcine Eye Model.
    J Ocul Pharmacol Ther. 2021 Oct 18. doi: 10.1089/jop.2021.0073.
    PubMed     Abstract available


  5. LIMON U, Sezgin Akcay BI
    Efficacy of Intravitreal Dexamethasone After Combined Phacoemulsification and Pars Plana Vitrectomy for Diabetic Tractional Retinal Detachments.
    J Ocul Pharmacol Ther. 2021 Oct 15. doi: 10.1089/jop.2021.0072.
    PubMed     Abstract available


  6. SARIGUL SEZENOZ A, Akkoyun I, Helvacioglu F, Haberal N, et al
    Antiproliferative and Mitochondrial Protective Effects of Apigenin in an Oxygen-Induced Retinopathy In Vivo Mouse Model.
    J Ocul Pharmacol Ther. 2021 Oct 15. doi: 10.1089/jop.2021.0046.
    PubMed     Abstract available


  7. TADEPALLI S, Farhath HP, Sudhir RR, Padmanabhan P, et al
    Reliability of Aqueous Flare Measurements During Uveitis by a Spot Fluorometer.
    J Ocul Pharmacol Ther. 2021 Oct 13. doi: 10.1089/jop.2021.0053.
    PubMed     Abstract available


  8. WU JH, Wang TH, Huang JY, Su CC, et al
    Ocular Surface Disease in Glaucoma Patients Randomized to Benzalkonium Chloride-Containing Latanoprost and Preservative-Free Bimatoprost.
    J Ocul Pharmacol Ther. 2021 Oct 4. doi: 10.1089/jop.2021.0071.
    PubMed     Abstract available


  9. KOLLI A, Toris CB, Reed DM, Gilbert J, et al
    The Effects of Topical Timolol and Latanoprost on Calculated Ocular Perfusion Pressure in Nonglaucomatous Volunteers.
    J Ocul Pharmacol Ther. 2021 Oct 4. doi: 10.1089/jop.2021.0068.
    PubMed     Abstract available


  10. HAN IC, Burnight ER, Kaalberg EE, Boyce TM, et al
    Chimeric Helper-Dependent Adenoviruses Transduce Retinal Ganglion Cells and Muller Cells in Human Retinal Explants.
    J Ocul Pharmacol Ther. 2021 Oct 1. doi: 10.1089/jop.2021.0057.
    PubMed     Abstract available


    September 2021
  11. KIM JH, Kim JW, Kim CG
    Five-Year Reactivation After Ranibizumab or Aflibercept Treatment for Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy.
    J Ocul Pharmacol Ther. 2021 Sep 14. doi: 10.1089/jop.2021.0051.
    PubMed     Abstract available


  12. NERI P, Pichi F
    SARS-CoV-2 and the Eye: The Pandora's Box of Ocular Immunology.
    J Ocul Pharmacol Ther. 2021 Sep 9. doi: 10.1089/jop.2021.0058.
    PubMed     Abstract available


  13. SANDER BP
    Prevention of Choroidal Thinning by 0.01% Atropine Administered 24 h Before Exposure to Hyperopic Blur in Young Myopes.
    J Ocul Pharmacol Ther. 2021 Sep 3. doi: 10.1089/jop.2021.0006.
    PubMed     Abstract available


  14. ZARBIN MA, Novack G
    N-of-1 Clinical Trials: A Scientific Approach to Personalized Medicine for Patients with Rare Retinal Diseases Such as Retinitis Pigmentosa.
    J Ocul Pharmacol Ther. 2021 Sep 3. doi: 10.1089/jop.2021.0059.
    PubMed     Abstract available


    August 2021
  15. GANGE WS, Qiao JB, Park PJ, McDonnell JF, et al
    Protection of Retinal Function by Nucleoside Reverse Transcriptase Inhibitors Following Retinal Ischemia/Reperfusion Injury.
    J Ocul Pharmacol Ther. 2021 Aug 26. doi: 10.1089/jop.2020.0083.
    PubMed     Abstract available


  16. SHARMA B, Soni D, Mohan RR, Sarkar D, et al
    Corticosteroids in the Management of Infectious Keratitis: A Concise Review.
    J Ocul Pharmacol Ther. 2021 Aug 26. doi: 10.1089/jop.2021.0040.
    PubMed     Abstract available


  17. GONZALEZ-SALINAS R, Yeu E, Holdbrook M, Baba SN, et al
    Collarette Elimination and Demodex Mite Eradication with Topical Lotilaner Ophthalmic Solution, 0.25.
    J Ocul Pharmacol Ther. 2021 Aug 20. doi: 10.1089/jop.2021.0011.
    PubMed     Abstract available


    July 2021
  18. THANUJA MY, Suma BS, Dinesh D, Ranganath SH, et al
    Microtubule Stabilization Protects Hypothermia-Induced Damage to the Cytoskeleton and Barrier Integrity of the Corneal Endothelial Cells.
    J Ocul Pharmacol Ther. 2021 Jul 2. doi: 10.1089/jop.2021.0036.
    PubMed     Abstract available


    June 2021
  19. SABANER MC, Dogan M, Akdogan M, Karadag S, et al
    Evaluation of Retinal and Choroidal Microcirculation Alterations After a Single Dose of Oral 5-mg Tadalafil: A Prospective Pilot Optical Coherence Tomography Angiography Study.
    J Ocul Pharmacol Ther. 2021 Jun 18. doi: 10.1089/jop.2020.0124.
    PubMed     Abstract available


    May 2021
  20. HOMMER N, Schmidl D, Kallab M, Bauer M, et al
    The Effect of Orally Administered Low-Dose Dronabinol on Retinal Blood Flow and Oxygen Metabolism in Healthy Subjects.
    J Ocul Pharmacol Ther. 2021 May 17. doi: 10.1089/jop.2020.0131.
    PubMed     Abstract available


  21. QIN T, Gao S, Wang W
    Celastrol Regulates the Secretion of Interleukin-17 in Patients with Sympathetic Ophthalmia Through Signal Transducer and Activator of Transcription 3.
    J Ocul Pharmacol Ther. 2021 May 17. doi: 10.1089/jop.2020.0128.
    PubMed     Abstract available


  22. VURAL E, Hazar L
    Assessment of Inflammation Biomarkers in Diabetic Macular Edema Treated with Intravitreal Dexamethasone Implant.
    J Ocul Pharmacol Ther. 2021 May 7. doi: 10.1089/jop.2020.0130.
    PubMed     Abstract available


  23. BEESON C, Peterson YK, Perron N, Bandyopadhyay M, et al
    Newly Identified Chemicals Preserve Mitochondrial Capacity and Decelerate Loss of Photoreceptor Cells in Murine Retinal Degeneration Models.
    J Ocul Pharmacol Ther. 2021 May 4. doi: 10.1089/jop.2020.0140.
    PubMed     Abstract available


  24. NOVACK GD
    Eyes on New Product Development: Regulations, Generics, and Disruptive Technologies.
    J Ocul Pharmacol Ther. 2021;37:191-192.
    PubMed    


  25. UCAR F, Cetinkaya S
    The Results of Preoperative Use of Topical Brimonidine in Strabismus Surgery.
    J Ocul Pharmacol Ther. 2021;37:230-235.
    PubMed     Abstract available


    April 2021
  26. ANDRADE N, Crispim Ribeiro J, Silva PM, Savio D, et al
    Effect of Topical Instillation of Pegaptanib Sodium Upon Inflammatory Corneal Neovascularization in Rabbits.
    J Ocul Pharmacol Ther. 2021 Apr 22. doi: 10.1089/jop.2020.0010.
    PubMed     Abstract available


  27. GELFMAN CM, Grishanin R, Bender KO, Nguyen A, et al
    Comprehensive Preclinical Assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therapy for the Treatment of Neovascular AMD and Diabetic Macular Edema.
    J Ocul Pharmacol Ther. 2021;37:181-190.
    PubMed     Abstract available


  28. SINGH RK, Binette F, Seiler M, Petersen-Jones SM, et al
    Pluripotent Stem Cell-Based Organoid Technologies for Developing Next-Generation Vision Restoration Therapies of Blindness.
    J Ocul Pharmacol Ther. 2021;37:147-156.
    PubMed     Abstract available


    March 2021
  29. ROY CHOWDHURY U, Kudgus RA, Holman BH, Rinkoski TA, et al
    Pharmacological Profile and Ocular Hypotensive Effects of Cromakalim Prodrug 1, a Novel ATP-Sensitive Potassium Channel Opener, in Normotensive Dogs and Nonhuman Primates.
    J Ocul Pharmacol Ther. 2021 Mar 30. doi: 10.1089/jop.2020.0137.
    PubMed     Abstract available


  30. ROWE-RENDLEMAN CL, Glickman R
    Regulations, Generics, and Disruptive Technologies in Ophthalmology: What Every Scientist Needs to Know.
    J Ocul Pharmacol Ther. 2021 Mar 17. doi: 10.1089/jop.2021.29078.
    PubMed    


  31. WANG RK, Jacques SL
    Innovative Optical Technologies in Ophthalmology and Eye Research.
    J Ocul Pharmacol Ther. 2021 Mar 17. doi: 10.1089/jop.2021.29077.
    PubMed    


  32. SALAS-AMBROSIO PJ, Bernad-Bernad MJ, Linares-Alba MA, Garcia-Santisteban R, et al
    Toxicity Evaluation of a Novel Rapamycin Liposomal Formulation After Subconjunctival and Intravitreal Injection.
    J Ocul Pharmacol Ther. 2021 Mar 10. doi: 10.1089/jop.2020.0108.
    PubMed     Abstract available


  33. NASONKIN IO
    Gene and Stem Cell-Based Therapies: Emerging Therapeutic Modalities in Ophthalmology.
    J Ocul Pharmacol Ther. 2021 Mar 4. doi: 10.1089/jop.2021.29076.
    PubMed    


  34. RETTINGER CL, Kaini RR, Burke TA, Wang HC, et al
    Neurotrophic Factors Secreted by Induced Pluripotent Stem Cell-Derived Retinal Progenitors Promote Retinal Survival and Preservation in an Adult Porcine Neuroretina Model.
    J Ocul Pharmacol Ther. 2021 Mar 3. doi: 10.1089/jop.2020.0088.
    PubMed     Abstract available


  35. NOVACK GD
    Eyes on New Product Development.
    J Ocul Pharmacol Ther. 2021;37:73-74.
    PubMed    


  36. OLIVERIO GW, Spinella R, Postorino EI, Inferrera L, et al
    Safety and Tolerability of an Eye Drop Based on 0.6% Povidone-Iodine Nanoemulsion in Dry Eye Patients.
    J Ocul Pharmacol Ther. 2021;37:90-96.
    PubMed     Abstract available


    February 2021
  37. FUWA M, Shimazaki A, Odani-Kawabata N, Kirihara T, et al
    Additive Intraocular Pressure-Lowering Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, Combined with Existing Antiglaucoma Agents in Conscious Ocular Normotensive Monkeys.
    J Ocul Pharmacol Ther. 2021 Feb 17. doi: 10.1089/jop.2020.0071.
    PubMed     Abstract available


  38. BASTIA E, Toris C, Bukowski JM, Brambilla S, et al
    NCX 1741, a Novel Nitric Oxide-Donating Phosphodiesterase-5 Inhibitor, Exerts Rapid and Long-Lasting Intraocular Pressure-Lowering in Cynomolgus Monkeys.
    J Ocul Pharmacol Ther. 2021 Feb 15. doi: 10.1089/jop.2020.0126.
    PubMed     Abstract available


  39. ARTUC T, Batur M, Seven E, Tekin S, et al
    Effectiveness of Pulmonary Surfactant in the Treatment of Corneal Edema.
    J Ocul Pharmacol Ther. 2021 Feb 8. doi: 10.1089/jop.2020.0121.
    PubMed     Abstract available


  40. QADRI A, Cai CL, Deslouches K, Siddiqui F, et al
    Ocular Versus Oral Propranolol for Prevention and/or Treatment of Oxygen-Induced Retinopathy in a Rat Model.
    J Ocul Pharmacol Ther. 2021 Feb 3. doi: 10.1089/jop.2020.0092.
    PubMed     Abstract available


  41. JIANG T, Zhang X, Zhou M, Jiang R, et al
    Prognosis of Ocular Tuberculosis Following Long-Term Antitubercular Therapy.
    J Ocul Pharmacol Ther. 2021 Feb 1. doi: 10.1089/jop.2020.0100.
    PubMed     Abstract available


    January 2021
  42. UCAN GUNDUZ G, Yalcinbayir O, Cekic S, Yildiz M, et al
    Anti-Tumor Necrosis Factor Treatment in the Management of Pediatric Noninfectious Uveitis: Infliximab Versus Adalimumab.
    J Ocul Pharmacol Ther. 2021 Jan 28. doi: 10.1089/jop.2020.0081.
    PubMed     Abstract available


  43. WANG R, Xia J, Tang J, Liu D, et al
    Surface Modification of Intraocular Lens with Hydrophilic Poly(Sulfobetaine Methacrylate) Brush for Posterior Capsular Opacification Prevention.
    J Ocul Pharmacol Ther. 2021 Jan 26. doi: 10.1089/jop.2020.0134.
    PubMed     Abstract available


  44. DINC E, Ayaz L, Kurt AH, Dursun O, et al
    Effects of Bone Marrow and Adipose-Derived Mesenchymal Stem Cells on microRNA Expressions in Acute Alkaline Corneal Burn.
    J Ocul Pharmacol Ther. 2021 Jan 21. doi: 10.1089/jop.2020.0107.
    PubMed     Abstract available


  45. CLARK D, Sheppard J, Brady TC
    A Randomized Double-Masked Phase 2a Trial to Evaluate Activity and Safety of Topical Ocular Reproxalap, a Novel RASP Inhibitor, in Dry Eye Disease.
    J Ocul Pharmacol Ther. 2021 Jan 15. doi: 10.1089/jop.2020.0087.
    PubMed     Abstract available


  46. TAKEDA N, Fukuda M, Sasaki H, Sugiyama K, et al
    The Effects of Antiglaucoma Ophthalmic Solutions on the Cornea Revealed by a Corneal Electrical Resistance Device.
    J Ocul Pharmacol Ther. 2021 Jan 13. doi: 10.1089/jop.2020.0077.
    PubMed     Abstract available


  47. EGUCHI H, Nishida K, Hotta F, Shimomura Y, et al
    In Vitro Antimicrobial Activity of Quinolones Against Major Bacterial Isolates from the Ocular Surface Bacterial Flora of Tertiary Hospital Patients in Japan.
    J Ocul Pharmacol Ther. 2021 Jan 4. doi: 10.1089/jop.2020.0091.
    PubMed     Abstract available


  48. GLICKMAN RD, Onorato M, Campos MM, O'Boyle MP, et al
    Intraocular Injection of HyStem Hydrogel Is Tolerated Well in the Rabbit Eye.
    J Ocul Pharmacol Ther. 2021;37:60-71.
    PubMed     Abstract available


  49. SHIN J, Rho CR, Hyon JY, Chung TY, et al
    A Randomized, Placebo-Controlled Phase II Clinical Trial of 0.01% or 0.02% Cyclosporin A with 3% Trehalose in Patients with Dry Eye Disease.
    J Ocul Pharmacol Ther. 2021;37:4-11.
    PubMed     Abstract available


  50. BOZKURT E, Muhafiz E, Yayla M, Cinar I, et al
    The Relationship of the Urotensin-2 Level in the Aqueous Humor with Systemic Diseases and Pupil Size: Comparative Study.
    J Ocul Pharmacol Ther. 2021;37:45-51.
    PubMed     Abstract available


    December 2020
  51. SHIRAI C, Matsuoka N, Nakazawa T
    Adherence and Persistence with First-Line Therapy and Compliance with Glaucoma Guidelines Using Japanese Health Care/Pharmacy Claims Database.
    J Ocul Pharmacol Ther. 2020 Dec 23. doi: 10.1089/jop.2020.0096.
    PubMed     Abstract available


  52. KAMIYA T, Omae T, Nakabayashi S, Takahashi K, et al
    Effect of Rho Kinase Inhibitor Ripasudil (K-115) on Isolated Porcine Retinal Arterioles.
    J Ocul Pharmacol Ther. 2020 Dec 22. doi: 10.1089/jop.2020.0082.
    PubMed     Abstract available


  53. SOMAYAJULU M, McClellan SA, Pitchaikannu A, Bessert D, et al
    Effects of Glycyrrhizin Treatment on Diabetic Cornea.
    J Ocul Pharmacol Ther. 2020 Dec 21. doi: 10.1089/jop.2020.0105.
    PubMed     Abstract available


  54. LUKE MC, Kozak D
    Regulating Generic Ophthalmologic Drug Bioequivalence-Envisioning Accessibility for Patients.
    J Ocul Pharmacol Ther. 2020 Dec 17. doi: 10.1089/jop.2020.0041.
    PubMed     Abstract available


  55. ALTUN A, Kanar HS, Aki SF, Arsan A, et al
    Effectiveness and Safety of Coadministration of Intravitreal Dexamethasone Implant and Silicone Oil Endotamponade for Proliferative Diabetic Retinopathy with Tractional Diabetic Macular Edema.
    J Ocul Pharmacol Ther. 2020 Dec 16. doi: 10.1089/jop.2020.0079.
    PubMed     Abstract available


  56. DINC E, Dursun O, Yilmaz G, Kurt AH, et al
    Evaluation of Anti-Inflammatory and Antiapoptotic Effects of Bone Marrow and Adipose-Derived Mesenchymal Stem Cells in Acute Alkaline Corneal Burn.
    J Ocul Pharmacol Ther. 2020 Dec 3. doi: 10.1089/jop.2020.0103.
    PubMed     Abstract available


  57. ALAGOZ N, Tellioglu A, Bektasoglu DL, Yasar T, et al
    Do We Conform with European Glaucoma Society Guidelines in the Medical Treatment of Primary Open-Angle Glaucoma/Ocular Hypertension? Data from a Real-Life Practice.
    J Ocul Pharmacol Ther. 2020;36:747-753.
    PubMed     Abstract available


    November 2020
  58. CUI W, Sun XY, Sun LP, Li J, et al
    Comparison of the Effect of Intravitreal Conbercept and Ranibizumab on Aqueous Humor Cytokines in Central Retinal Vein Occlusion-Related Macular Edema.
    J Ocul Pharmacol Ther. 2020 Nov 19. doi: 10.1089/jop.2020.0035.
    PubMed     Abstract available


  59. DUTESCU RM, Uthoff D, Panfil C, Schrage N, et al
    High-Frequency Application of Cationic Agents Containing Lubricant Eye Drops Causes Cumulative Corneal Toxicity in an Ex Vivo Eye Irritation Test Model.
    J Ocul Pharmacol Ther. 2020 Nov 11. doi: 10.1089/jop.2020.0043.
    PubMed     Abstract available


  60. KECIK D, Grabska-Liberek I, Jurowski P, Mrukwa-Kominek E, et al
    Stable Mydriasis After Intracameral Injection of a Combination of Mydriatics and Anesthetic During Cataract Surgery: A Real-Life, Multicenter Study.
    J Ocul Pharmacol Ther. 2020 Nov 4. doi: 10.1089/jop.2020.0001.
    PubMed     Abstract available


    October 2020
  61. QIN C, Wen S, Zhu S, Liu D, et al
    Are Poly(amidoamine) Dendrimers Safe for Ocular Applications? Toxicological Evaluation in Ocular Cells and Tissues.
    J Ocul Pharmacol Ther. 2020 Oct 29. doi: 10.1089/jop.2020.0078.
    PubMed     Abstract available


  62. FU D, Yu JY, Connell AR, Hookham MB, et al
    Effects of Modified Low-Density Lipoproteins and Fenofibrate on an Outer Blood-Retina Barrier Model: Implications for Diabetic Retinopathy.
    J Ocul Pharmacol Ther. 2020 Oct 27. doi: 10.1089/jop.2020.0068.
    PubMed     Abstract available


    September 2020
  63. MANDELL KJ, Clark D, Chu DS, Foster CS, et al
    Randomized Phase 2 Trial of Reproxalap, a Novel Reactive Aldehyde Species Inhibitor, in Patients with Noninfectious Anterior Uveitis: Model for Corticosteroid Replacement.
    J Ocul Pharmacol Ther. 2020 Sep 22. doi: 10.1089/jop.2020.0056.
    PubMed     Abstract available


    March 2020
  64. NOVACK GD
    Eyes on New Product Development.
    J Ocul Pharmacol Ther. 2020;36:73-74.
    PubMed    


  65. LEE JH, Lee SC, Lee CS
    Comparison of Half-Time and Half-Irradiance Photodynamic Therapy in Nonresolving Central Serous Chorioretinopathy.
    J Ocul Pharmacol Ther. 2020;36:109-115.
    PubMed     Abstract available


  66. LI Y, Jin R, Li L, Hsu HH, et al
    Therapeutic Effect of Topical Adiponectin-Derived Short Peptides Compared with Globular Adiponectin in Experimental Dry Eye and Alkali Burn.
    J Ocul Pharmacol Ther. 2020;36:88-96.
    PubMed     Abstract available


    January 2020
  67. NOVACK GD
    Eyes on New Product Development.
    J Ocul Pharmacol Ther. 2020;36:1-2.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Ophthalmology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: